Not finding it? Sign in to also search OpenAlex live.
-
POS0484 CHARACTERISATION OF METHOTREXATE INITIATION COHORTS ACROSS EUROPEAN RHEUMATOID ARTHRITIS REGISTRIES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
C.A. Hana, T.L.V. Tran, Nils Steinz, D. Di Giuseppe, J. Sexton, Corina Mogoşan, +9 more
0citations -
Real-World Clinical Outcomes for Complement Inhibitor Experienced and Naïve Paroxysmal Nocturnal Hemoglobinuria Patients Prescribed Pegcetacoplan in Europe and Canada2024 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Jens Panse, Juan Carlos Vallejo Llamas, Koo Wilson, Zalmaï Hakimi, Barbara Czech, Sam Williamson, +4 more
1citations -
Group consultations for socioeconomically vulnerable cardiometabolic risk groups: from implementation to integration into standard practice2026 International Journal of Integrated Care conference-abstract Health Professions Health Policy Implementation Science Open access
Jonne G. ter Braake, Eline Frouke de Vries, Sander Steenhuis, Annefrans F. T. M. van Ede, Tara Kwakkernaat, Maud J. Verhoeven, +2 more
0citations -
Real-world clinical characteristics and treatment outcomes in PNH patients prescribed pegcetacoplan across europe, the United States and Canada2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Jens Panse, Koo Wilson, Sam Williamson, Susanna Libby, Peter Hillmen, David Dingli
0citations -
Real-world effectiveness of reslizumab in patients with severe eosinophilic asthma – “first initiators” and “switchers”2022 05.01 - Airway pharmacology and treatment conference-abstract Medicine Asthma and respiratory diseases
Simone Hashimoto, Johannes Anthon Kroes, Katrien A.B. Eger, Pearl Mau-Asam, Hendrik B. Hofstee, Sarah Bendien, +19 more
2citations -
POS1123 IMPACT OF THE TIME OF INITIATION AND LINE OF BIOLOGIC THERAPY ON THE RETENTION RATE OF SECUKINUMAB (SECU) IN AXIAL SPONDYLOARTHRITIS (AXSPA). DATA FROM THE FRENCH MULTICENTER RETROSPECTIVE FORSYA STUDY
Maxime Dougados, A. Lardy-Cléaud, E. Desfleurs, Pascal Claudepierre, Philippe Goupille, A. Ruyssen-Witrand, +4 more
1citations -
Evaluation of early C-reactive protein kinetics as an early response marker in biliary tract cancer patients treated with combined chemoimmunotherapy.2026 Journal of Clinical Oncology conference-abstract Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Gabriel Allo, Joshua Leutiger, Catherine Leyh, Christian Moehring, Ann-Kristin Zoeller, Vera Himmelsbach, +11 more
1citations -
Abstract P2-14-07: Association between initiation of adjuvant chemotherapy beyond 30 days following surgery and overall survival among patients with triple-negative breast cancer2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Erik Heeg, Perla J. Marang‐van de Mheen, Marissa Corine van Maaren, Kay Schreuder, Rob A.�E.�M. Tollenaar, Sabine Siesling, +2 more
0citations -
MO514: Cardiorenal Outcomes Associated With Oral Anticoagulant Use in Patients With Atrial Fibrillation2022 Nephrology Dialysis Transplantation conference-abstract Medicine Atrial Fibrillation Management and Outcomes
Faizan Mazhar, Marco Trevisan, Paul Hjemdahl, Catherine M. Clase, Ype de Jong, Marie Evans, +3 more
0citations -
Monotherapy Treatment with Zaltenibart (OMS906), an Alternative Pathway Masp-3 Inhibitor, Improved Key Hematologic Parameters in Patients with PNH with a Suboptimal Response to Ravulizumab: Interim Results from a Phase 2 Proof-of-Concept Study
Morag Griffin, Richard J. Kelly, Mathilde Gavillet, Petra Muus, Britta Hoechsmann, W. Jason Cummings, +4 more
4citations -
Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study
Julia Marie Unglaub, Richard F. Schlenk, Maher Hanoun, Hans Christian Reinhardt, Jan Moritz Middeke, Kerstin Schäfer‐Eckart, +30 more
4citations -
Adjuvant hepatic arterial infusion pump chemotherapy with floxuridine for patients with resectable colorectal liver metastases and a low clinical risk score: A randomized controlled trial—The PUMP trial.2026 Journal of Clinical Oncology conference-abstract Medicine Colorectal Cancer Treatments and Studies
Loubna Outmani, Florian Buisman, Wills F. Filipe, Karen Bolhuis, Leni van Doorn, Pascal Gabriël Doornebosch, +14 more
3citations -
Initial soil formation in an artificial river valley - Interplay of anthropogenic landscape shaping and fluvial dynamics2022 conference-abstract Agricultural and Biological Sciences Soil and Environmental Studies Open access
Philipp Schulte, Hendrik Hamacher, Frank Lehmkuhl, Verena Esser
0citations